• Publications
  • Influence
IL-17 in cutaneous lupus erythematosus.
IL- 17 isoforms (IL-17A and IL-17F) are implicated in SLE but also in DLE and SCLE immunopathogenesis, with correlative study between local and serological expression. Expand
Pharmacological treatment in calcinosis cutis associated with connective-tissue diseases.
The general trends observed over time are of switching the search of solutions in dystrophic calcinosis cutis related to connective tissue diseases, from therapies on calcium metabolism to therapies for the underlying disease. Expand
T helper 17 cell population in lupus erythematosus.
The findings suggest that IL-17 is implicated not only in SLE but also in DLE and SCLE immunopathogenesis, and Th17 lymphocytes are implicated in LE pathogenesis. Expand
Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
BACKGROUND AND AIMS Mucosal healing is an important predictor of disease-related outcome in patients with inflammatory bowel disease (IBD) patients, including those in clinical remission. However,Expand
Th17 and IL-17 immunity in chronic hepatitis C infection.
Novel intriguing data indicate that Th17 boost could be associated with spontaneous HCV clearance and could play a dual role (both beneficial and harmful) and that an unbalance of regulating factors rather than the lymphocyte itself could tip the Th17 immune response one way or another. Expand
Romanian version of SDM-Q-9 validation in Internal Medicine and Cardiology setting: a multicentric cross-sectional study
SDM-Q-9 is a useful tool for evaluation and improvement in health care that was validated in Romania and can be used in clinical setting in this country. Expand
Serum endocan levels are increased in patients with inflammatory bowel disease.
There is a potential role for endocan in future biomarker studies in IBD patients, and levels were significantly higher in the IBD group as compared to both healthy controls and cancer patients. Expand
Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review
Critically review proteomic studies that used mass spectrometry techniques and summarize relevant proteomic NAFLD candidate biomarkers to identify some of the biomarkers identified that have already been extensively studied regarding their diagnostic and prognostic capacity. Expand
Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study
Endocan is expressed by endothelial cells and associated with endothelial dysfunction; therefore it could be a potential biomarker for Ssc patients. Expand
IL-17, IL-6 and IFN-γ in systemic sclerosis patients
Th17 and Th1 cell responses are active in Ssc patients as their cytokines associated with higher disease activity scores and pulmonary manifestations, including higher serum IFN-γ levels associated with pulmonary hypertension. Expand